IntraLase

ViaLase Founder and CEO Tibor Juhasz, Ph.D., Receives 2022 Golden Goose Award

Retrieved on: 
Wednesday, September 28, 2022
American Association for the Advancement of Science, University of Waterloo, Laser, Golden Goose Award, Glaucoma, Society, LinkedIn, Health, Femtosecond, American Association, Industry, Patient, Flight, CEO, Technology, Cataract, AAAS, CA, IntraLase, American Association of Endocrine Surgeons, Research, Association, University, Pharmaceutical industry, Medical imaging, Dentistry, Science, Optica

ALISA VIEJO, Calif., Sept. 28, 2022 /PRNewswire/ -- ViaLase, Inc., today announced that the company's founder and CEO, Tibor Juhasz, Ph.D., was among five researchers who received the 2022 Golden Goose Award for scientific breakthroughs leading to the development of bladeless LASIK, an innovation that revolutionized refractive surgery. The award, which was presented by the American Association for the Advancement of Science (AAAS), honors scientists whose federally funded research has unexpectedly benefited society. 

Key Points: 
  • ALISA VIEJO, Calif., Sept. 28, 2022 /PRNewswire/ -- ViaLase, Inc., today announced that the company's founder and CEO, Tibor Juhasz, Ph.D., was among five researchers who received the 2022 Golden Goose Award for scientific breakthroughs leading to the development of bladeless LASIK, an innovation that revolutionized refractive surgery.
  • The award, which was presented by the American Association for the Advancement of Science (AAAS), honors scientists whose federally funded research has unexpectedly benefited society.
  • Alongside his fellow researchers, Dr. Juhasz discovered the femtosecond laser's capacity to create ocular tissue incisions with micron-level precision without damaging adjacent tissue.
  • The award is presented by the American Association for the Advancement of Science (AAAS), the world's largest multidisciplinary scientific society.

Saluda Medical Appoints Robert Palmisano to Board of Directors

Retrieved on: 
Wednesday, April 20, 2022
Board, CEO, The Lancet, Neurology, Webbed toes, Lists of diseases, Covidien, RCT, Board of directors, SCS, JAMA Neurology, PMA, EV3, Providence College, IntraLase, Randomized controlled trial, Bausch & Lomb, History, Safety, Multimedia, Record, Low back pain, Pharmaceutical industry, Management, Bausch

ARTARMON, Australia, April 20, 2022 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies designed to treat debilitating neurological disorders, today announced the appointment of Robert (Bob) Palmisano to its Board of Directors.

Key Points: 
  • ARTARMON, Australia, April 20, 2022 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies designed to treat debilitating neurological disorders, today announced the appointment of Robert (Bob) Palmisano to its Board of Directors.
  • "We are incredibly fortunate to welcome Bob to Saluda and believe he will add significant value to our board of directors."
  • Previously, Mr. Palmisano was President & CEO of Wright Medical Group, Inc., a position he held since September 2011 before being acquired by Stryker Medical for $5.3B in 2020.
  • Mr. Palmisano currently serves on the RxSight Board of Directors, previously serving as the Chairman of the Board of Avedro, Inc. acquired by Glaukos Corporation in 2019 and served on the Board of Directors of Bausch & Lomb, ev3, Inc., Osteotech, Inc., and Abbott Medical Options, Inc.

RxSight Announces Appointments to its Board of Directors

Retrieved on: 
Wednesday, August 11, 2021
Bausch, Visual acuity, Rutgers University, Medtronic, Company, Patient, MBA, Accounting, Technology, Forward-looking statement, GRACE, Senior, IntraLase, Community Exchange System, Spine, Providence College, Financial system, LAL, Terminology, General manager, Pace University, BS, Nasdaq, Board, University, Leadership, Acquisition, Board of directors, IOL, GLOBE, Bausch & Lomb, Growth, Small Business Saturday, Management

The three appointments, including Robert (Bob) Palmisano, Robert Warner and Julie Andrews, joined directors J. Andy Corley, William J.

Key Points: 
  • The three appointments, including Robert (Bob) Palmisano, Robert Warner and Julie Andrews, joined directors J. Andy Corley, William J.
  • Concurrent with the new appointments, the Company announced the resignations of four long-serving board members Bruce Robertson, Ph.D., Daniel Schwartz, M.D., Christopher Cox, and Rick Wolfen.
  • We are excited to welcome Bob, Robert and Julie to the RxSight Board of Directors as we move forward as a public company focused on improving patient vision after cataract surgery.
  • Their shared values and collective expertise across commercial operations, finance and strategy will play a crucial guiding role in the next phase of growth for RxSight, said J. Andy Corley, Chair of the Board of Directors.